COMPANY UPDATES
02
Jan
2014
Novoheart Limited is incorporated

Novoheart Limited is incorporated in Hong Kong on 2 January 2014, with the vision of revolutionizing drug discovery and development of heart therapeutics with proprietary bioengineered human heart constructs, and further developing them into transplantable grafts for cell-based regenerative therapies with superior safety and efficacy.

Subscribe To Our Newsletter

Fill out the following to subscribe and start receiving updates from us!